Share-based Payment Arrangement, Expense of EKSO BIONICS HOLDINGS, INC. from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
EKSO BIONICS HOLDINGS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • EKSO BIONICS HOLDINGS, INC. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $783,000, a 156% increase year-over-year.
  • EKSO BIONICS HOLDINGS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $1,474,000, a 7.4% increase year-over-year.
  • EKSO BIONICS HOLDINGS, INC. annual Share-based Payment Arrangement, Expense for 2025 was $1,474,000, a 7.4% increase from 2024.
  • EKSO BIONICS HOLDINGS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $1,373,000, a 26% decline from 2023.
  • EKSO BIONICS HOLDINGS, INC. annual Share-based Payment Arrangement, Expense for 2023 was $1,858,000, a 27% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

EKSO BIONICS HOLDINGS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,474,000 $783,000 +$477,000 +156% 01 Oct 2025 31 Dec 2025 10-K 23 Feb 2026 2025 FY
Q3 2025 $997,000 $234,000 -$172,000 -42% 01 Jul 2025 30 Sep 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 $1,169,000 $207,000 -$78,000 -27% 01 Apr 2025 30 Jun 2025 10-Q 28 Jul 2025 2025 Q2
Q1 2025 $1,247,000 $250,000 -$126,000 -34% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 $1,373,000 $306,000 -$173,000 -36% 01 Oct 2024 31 Dec 2024 10-K 23 Feb 2026 2025 FY
Q3 2024 $1,546,000 $406,000 -$35,000 -7.9% 01 Jul 2024 30 Sep 2024 10-Q 28 Oct 2025 2025 Q3
Q2 2024 $1,581,000 $285,000 -$229,000 -45% 01 Apr 2024 30 Jun 2024 10-Q 28 Jul 2025 2025 Q2
Q1 2024 $1,810,000 $376,000 -$48,000 -11% 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025 2025 Q1
Q4 2023 $1,858,000 $479,000 -$449,000 -48% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $2,307,000 $441,000 -$96,000 -18% 01 Jul 2023 30 Sep 2023 10-Q 28 Oct 2024 2024 Q3
Q2 2023 $2,403,000 $514,000 -$68,000 -12% 01 Apr 2023 30 Jun 2023 10-Q 29 Jul 2024 2024 Q2
Q1 2023 $2,471,000 $424,000 -$75,000 -15% 01 Jan 2023 31 Mar 2023 10-Q 29 Apr 2024 2024 Q1
Q4 2022 $2,546,000 $928,000 +$137,000 +17% 01 Oct 2022 31 Dec 2022 10-K 04 Mar 2024 2023 FY
Q3 2022 $2,409,000 $537,000 -$126,000 -19% 01 Jul 2022 30 Sep 2022 10-Q 26 Oct 2023 2023 Q3
Q2 2022 $2,535,000 $582,000 +$63,000 +12% 01 Apr 2022 30 Jun 2022 10-Q 27 Jul 2023 2023 Q2
Q1 2022 $2,472,000 $499,000 +$143,000 +40% 01 Jan 2022 31 Mar 2022 10-Q 27 Apr 2023 2023 Q1
Q4 2021 $2,329,000 $791,000 -$7,000 -0.88% 01 Oct 2021 31 Dec 2021 10-K 28 Mar 2023 2022 FY
Q3 2021 $2,336,000 $663,000 +$146,000 +28% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $2,190,000 $519,000 +$11,000 +2.2% 01 Apr 2021 30 Jun 2021 10-Q 28 Jul 2022 2022 Q2
Q1 2021 $2,179,000 $356,000 -$231,000 -39% 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022 2021 Q1
Q4 2020 $2,410,000 $798,000 +$223,000 +39% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $2,187,000 $517,000 +$30,000 +6.2% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 $2,157,000 $508,000 -$49,000 -8.8% 01 Apr 2020 30 Jun 2020 10-Q 29 Jul 2021 2021 Q2
Q1 2020 $2,206,000 $587,000 -$49,000 -7.7% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021 2021 Q1
Q4 2019 $2,255,000 $575,000 -$61,000 -9.6% 01 Oct 2019 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $2,316,000 $487,000 -$451,000 -48% 01 Jul 2019 30 Sep 2019 10-Q 29 Oct 2020 2020 Q3
Q2 2019 $2,767,000 $557,000 +$155,000 +39% 01 Apr 2019 30 Jun 2019 10-Q 30 Jul 2020 2020 Q2
Q1 2019 $2,612,000 $636,000 -$256,000 -29% 01 Jan 2019 31 Mar 2019 10-Q 30 Apr 2020 2020 Q1
Q4 2018 $2,868,000 $636,000 -$25,000 -3.8% 01 Oct 2018 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 $2,893,000 $938,000 +$288,000 +44% 01 Jul 2018 30 Sep 2018 10-Q 30 Oct 2019 2019 Q3
Q2 2018 $2,605,000 $402,000 -$307,000 -43% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019 2019 Q2
Q1 2018 $2,912,000 $892,000 +$498,000 +126% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019 2019 Q1
Q4 2017 $2,414,000 $661,000 +$92,000 +16% 01 Oct 2017 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 $2,322,000 $650,000 +$199,000 +44% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $2,123,000 $709,000 +$182,000 +35% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 $1,941,000 $394,000 -$1,180,000 -75% 01 Jan 2017 31 Mar 2017 10-Q 07 May 2018 2018 Q1
Q4 2016 $3,121,000 $569,000 +$97,000 +21% 01 Oct 2016 31 Dec 2016 10-K 13 Mar 2018 2017 FY
Q3 2016 $3,024,000 $451,000 -$16,000 -3.4% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q2 2016 $3,040,000 $527,000 +$84,000 +19% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q2
Q1 2016 $2,956,000 $1,574,000 +$1,225,000 +351% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q4 2015 $1,731,000 $472,000 +$139,000 +42% 01 Oct 2015 31 Dec 2015 10-K 13 Mar 2018 2017 FY
Q3 2015 $1,592,000 $467,000 +$350,000 +299% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 $1,242,000 $443,000 +$117,000 +36% 01 Apr 2015 30 Jun 2015 10-Q 03 Aug 2016 2016 Q2
Q1 2015 $1,125,000 $349,000 -$18,000 -4.9% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q4 2014 $1,143,000 $333,000 +$220,154 +195% 01 Oct 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
Q3 2014 $922,846 $117,000 +$9,367 +8.7% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3
Q2 2014 $913,479 $326,000 +$241,634 +286% 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015 2015 Q2
Q1 2014 $671,845 $367,000 +$280,845 +326% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q4 2013 $391,000 $112,846 01 Oct 2013 31 Dec 2013 10-K 14 Mar 2016 2015 FY
Q3 2013 $107,633 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014 2014 Q3
Q2 2013 $84,366 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2014 2014 Q2
Q1 2013 $86,155 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014 2014 Q1

EKSO BIONICS HOLDINGS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,474,000 +$101,000 +7.4% 01 Jan 2025 31 Dec 2025 10-K 23 Feb 2026 2025 FY
2024 $1,373,000 -$485,000 -26% 01 Jan 2024 31 Dec 2024 10-K 23 Feb 2026 2025 FY
2023 $1,858,000 -$688,000 -27% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
2022 $2,546,000 +$217,000 +9.3% 01 Jan 2022 31 Dec 2022 10-K 04 Mar 2024 2023 FY
2021 $2,329,000 -$81,000 -3.4% 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2023 2022 FY
2020 $2,410,000 +$155,000 +6.9% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022 2021 FY
2019 $2,255,000 -$613,000 -21% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2021 2020 FY
2018 $2,868,000 +$454,000 +19% 01 Jan 2018 31 Dec 2018 10-K 27 Feb 2020 2019 FY
2017 $2,414,000 -$707,000 -23% 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2019 2018 FY
2016 $3,121,000 +$1,390,000 +80% 01 Jan 2016 31 Dec 2016 10-K 13 Mar 2018 2017 FY
2015 $1,731,000 +$588,000 +51% 01 Jan 2015 31 Dec 2015 10-K 13 Mar 2018 2017 FY
2014 $1,143,000 +$752,000 +192% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
2013 $391,000 +$58,000 +17% 01 Jan 2013 31 Dec 2013 10-K 14 Mar 2016 2015 FY
2012 $333,000 01 Jan 2012 31 Dec 2012 10-K 19 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.